Pharma Focus Asia

Full-Life Technologies Commences Construction on State-of-the-Art GMP Manufacturing Facility in Belgium, Europe

Introduction:

Full-Life Technologies breaks ground for GMP manufacturing facility to advance its end-to-end solution for radiopharmaceuticals in Belgium, Europe.

Features:

The 4,000 square metre, state-of-the-art facility is designed as a production hub, seamlessly blending sustainable practises with automation and digital quality assurance systems.

Spanning 17,000 square metres, this facility is designed to cater to the production of a diverse range of radiopharmaceuticals, emphasising its specialised and comprehensive approach within the field.

It aims to enhance comprehensive solution by boosting its ability to manufacture radiopharmaceuticals at the logistical hub, ensuring timely global delivery to patients.

This facility will ensure a establish a consistent and dependable supply chain for clinical development. Additionally, it boasts a robust logistical network, further enhancing the efficiency and effectiveness of operations within the region.

At its core, the facility prioritises maintaining stringent control, reliability, and cost-effectiveness within its supply chain. 

Specifications:

Name    Full-Life Technologies
Type      New Construction


 

magazine-slider-imageHexagon - Expert Insights WebinarMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference